In the current environment, investment in the biotech stocks could be a risky recommendation for the investors. Despite its erratic...
Biotech company Moderna raised above $600 million on Thursday by selling about 26 million of its common stock at $23...
Takeda Pharmaceutical and Shire Plc announced that their shareholders have approved the $62 billion merger transaction. Takeda said that at...
Arena Pharmaceuticals (ARNA) inked a deal with United Therapeutics (UTHR) to sell and develop its Phase 3 investigational drug candidate...
Amarin Corporation (AMRN) shares turned to green Wednesday after they were battered out in the last two days following the...
Celgene Corp. (CELG) reported better-than-expected profit and revenue numbers for the third quarter of 2018 on strong product sales. Revenue...
Clinical stage biopharma company Proteostasis Therapeutics (PTI) announced positive preliminary results from a Phase 1 study for the treatment of...
Amarin Corporation (AMRN) announced positive results from a clinical study in which Vascepa, an EPA drug, was used to treat...
In the midst of Amgen (AMGN) facing intense competition for its blockbuster products from its rivals, the pharma company posted...
It’s no big secret that investment in biotech stocks can offer great returns for investors, and at the same time...
U.S. Food and Drug Administration (FDA) has sent a “Refuse to file” letter to Celgene with regards to the New...
